BioPhenoMA

Tokyo, Japan

BioPhenoMA develops an AI-powered platform for detecting ultra-trace proteins that helps accelerate new drug discovery phases.

$1.2M raised

Nov 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BioPhenoMA raised?

BioPhenoMA has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in November 2024.

Who are BioPhenoMA's investors?

BioPhenoMA's investors include JMTC Capital, WASEDA University Ventures.

Where is BioPhenoMA headquartered?

BioPhenoMA is headquartered in Tokyo, Japan.

What does BioPhenoMA do?

BioPhenoMA develops an AI-powered platform for detecting ultra-trace proteins that helps accelerate new drug discovery phases.

What stage is BioPhenoMA at?

BioPhenoMA is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 7, 2024.

MLA

"BioPhenoMA — Funding & Investors." VCBacked, November 7, 2024, https://www.vcbacked.co/company/biophenoma. Accessed July 3, 2026.

APA

VCBacked. (2024). BioPhenoMA — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/biophenoma

Wikipedia (cite web)

{{cite web |title=BioPhenoMA — Funding & Investors |url=https://www.vcbacked.co/company/biophenoma |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 7, 2024.